Food and Drug Administration evaluation and cigarette smoking risk perceptions
Annette R Kaufman1, Erika A Waters, Mark Parascandola
1Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA. kaufmana@mail.nih.gov
Objectives:
To examine the relationship between a belief about Food and Drug Administration (FDA) safety evaluation of cigarettes and smoking risk perceptions.
Methods:
A nationally representative, random-digit-dialed telephone survey of 1046 adult current cigarette smokers.
Results:
Smokers reporting that the FDA does not evaluate cigarettes for safety (46.1%), exhibited greater comprehension of the health risks of smoking and were more likely (48.5%) than other participants (33.6%) to report quit intentions. Risk perceptions partially mediated the relationship between FDA evaluation belief and quit intentions.
Conclusions:
These findings highlight the need for proactive, effective communication to the public about the aims of new tobacco product regulations.
More Related Videos
Related Concept Videos
Drug Regulation
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Statistical Methods for Analyzing Epidemiological Data
Cancer Prevention
Some...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Criteria for Causality: Bradford Hill Criteria - II


